Prelude Therapeutics
PRLD
PRLD
62 hedge funds and large institutions have $41M invested in Prelude Therapeutics in 2024 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 26 increasing their positions, 12 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 16
Holders
62
Holding in Top 10
–
Calls
$8K
Puts
–
Top Buyers
| 1 | +$627K | |
| 2 | +$558K | |
| 3 | +$523K | |
| 4 |
Millennium Management
New York
|
+$385K |
| 5 |
Two Sigma Advisers
New York
|
+$321K |
Top Sellers
| 1 | -$7.8M | |
| 2 | -$1.91M | |
| 3 | -$1.84M | |
| 4 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$583K |
| 5 |
Walleye Capital
New York
|
-$172K |